Median | p value | |
---|---|---|
Iodine density (mg/mL) | < 0.001 | |
Non-metastatic contralateral | 0.93 ± 0.27 | |
Inguinal lymph node | 3.77 ± 0.14 | |
Spectral slope | < 0.001 | |
Non-metastatic contralateral | 0.51 ± 0.83 | |
Inguinal lymph node | 2.36 ± 0.91 | |
Z effective | < 0.001 | |
Non-metastatic contralateral | 205 ± 53.8 | |
Inguinal lymph node | 79 ± 42.7 | |
Conventional CT HU | < 0.001 | |
Non-metastatic contralateral | 24.4 ± 26.4 | |
Inguinal lymph node | 69.7 ± 26.6 | |
VNC (HU) | ||
Non-metastatic contralateral | 9.4 ± 19.2 | 0.092 |
Inguinal lymph node | 16.8 ± 14.8 | |
Δ contrast enhancement (HU) | < 0.001 | |
Non-metastatic contralateral | 12.6 ± 2.2 | |
Inguinal lymph node | 50.6 ± 1.4 |